Related Experiment Video
Updated: May 7, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
17.7K
Promising biomarkers for systemic lupus erythematosus
Ju-Yang Jung1, Chang-Bum Bae, Chang-Hee Suh
1Ajou University School of Medicine, Department of Rheumatology , 164 Worldcup-ro, Yeongtong-gu, Suwon 443-380 , Korea.
Expert Opinion on Medical Diagnostics
|October 9, 2013
Summary
Identifying reliable biomarkers for Systemic Lupus Erythematosus (SLE) is crucial for assessing disease activity and guiding treatment. Current lupus biomarkers lack validation for monitoring disease progression and treatment efficacy.
Area of Science:
- Immunology
- Rheumatology
- Autoimmune Diseases
Background:
- Systemic Lupus Erythematosus (SLE) is a complex autoimmune condition with varied clinical presentations.
- Accurate assessment of SLE disease activity and informed therapeutic decisions are critical for patient management.
- There is a growing need for reliable biomarkers indicating pathogenic processes, disease activity, and treatment response in SLE.
Purpose of the Study:
- To review established and emerging biomarkers for Systemic Lupus Erythematosus (SLE).
- To categorize biomarkers based on their diagnostic utility, role in assessing disease activity, and association with organ involvement.
Main Methods:
- Literature review of well-studied and newly discovered biomarkers for SLE.
- Categorization of biomarkers into diagnostic, disease activity, and organ involvement groups.
Main Results:
- The article presents a comprehensive overview of various biomarkers relevant to SLE.
- Identified biomarkers span diagnostic, prognostic, and monitoring applications.
Conclusions:
- The absence of validated biomarkers hinders accurate SLE disease activity assessment and treatment evaluation.
- Longitudinal and interventional studies are needed to confirm biomarker utility in monitoring SLE.
- Future directions include collaborative research, standardized assays, multiplexed approaches, and high-throughput technologies like microarrays and proteomics.
